Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 120,898 | 115,300 | 125,139 | 117,985 | 118,745 |
| Cost of Goods | 97,957 | 96,952 | 96,987 | 92,918 | 93,841 |
| Gross Profit | 22,941 | 18,348 | 28,152 | 25,067 | 24,904 |
| Operating Expenses | 12,246 | 19,691 | 14,939 | 19,345 | 12,945 |
| Operating Income | 11,652 | -391 | 14,200 | 6,640 | 12,800 |
| Interest Expense | 2,707 | 2,644 | 2,590 | 2,669 | 2,530 |
| Pre-tax Income | 8,945 | -3,035 | 11,610 | 3,971 | 10,270 |
| Income Tax | 1,789 | -1,196 | 8,824 | 2,962 | 2,053 |
| Net Income Continuous | 7,156 | -1,839 | 2,786 | 1,009 | 8,217 |
| Minority Interests | 90 | 49 | 98 | 135 | 157 |
| Net Income | $7,066 | $-1,888 | $2,688 | $874 | $8,060 |
| EPS Basic Total Ops | 0.15 | -0.04 | 0.07 | 0.02 | 0.17 |
| EPS Basic Continuous Ops | 0.15 | -0.04 | 0.06 | 0.02 | 0.18 |
| EPS Diluted Total Ops | 0.15 | -0.04 | 0.06 | 0.02 | 0.17 |
| EPS Diluted Continuous Ops | 0.15 | -0.04 | 0.06 | 0.02 | 0.17 |
| EBITDA(a) | $16,012 | $4,166 | $18,598 | $11,136 | $17,551 |